Infection Prevention Expert Dr. Bill Rutala Joins Kinnos Advisory Board

NEW YORK, October 19, 2017 – Kinnos Inc. is pleased to welcome Dr. Bill Rutala, MS, MPH, PhD, to the company’s Advisory Board, joining industry experts Nahid Bhadelia, John DeFord, and Elias Shaheen. Dr. Rutala will serve a critical role in advancing the development and reach of Kinnos’s flagship Highlight® technology.

Last month, Kinnos unveiled its Highlight® Wipes technology to combat healthcare-associated infections (HAIs). HAIs affect 1 out of every 25 patients, leading to 75,000 deaths and costing the US healthcare system more than $28bn every year. Over the past five years, the importance of environmental cleaning in the prevention of infection transmission has become increasingly clear; however, human error and non-compliance with full coverage and contact times can render disinfection processes ineffective. With guidance from Dr. Rutala, Highlight® Wipes will be piloted in leading hospitals this quarter to address these deficiencies in environmental cleaning through its patent-pending color and color-fading mechanism.

“We’re incredibly excited to build off of Dr. Rutala’s groundbreaking work to advance our Highlight® technology for infection prevention,” said CEO Jason Kang. “Dr. Rutala’s intimate knowledge of disinfection technologies and hospital practices will allow us to rapidly expand in the healthcare space.”

Dr. Rutala is the Director and co-founder of the Statewide Program for Infection Control and Epidemiology and a Research Professor for the Division of Infectious Diseases at the University of North Carolina’s School of Medicine. He was the Director of Hospital Epidemiology, Occupational Health and Safety Program at the University of North Carolina Hospitals for 38 years before retiring in 2017. He has been an advisor to the Centers for Disease Control and Prevention, the Food and Drug Administration, the U.S. Environmental Protection Agency, and the Federal Trade Commission. Dr. Rutala is a member of various committees on the local, state, national and international level as well as several professional societies including the American Society for Microbiology, Association for Professionals in Infection Control and Epidemiology and the Society of Healthcare Epidemiology of America, and serves on the editorial board of the Infection Control and Hospital Epidemiology and The Journal of Hospital Infection. He has more than 600 publications in the fields of disinfection and sterilization to include several guidelines (e.g., CDC Guideline for Disinfection and Sterilization in Healthcare Facilities), and the epidemiology and prevention of healthcare-associated infections. Dr. Rutala holds the distinction as the only person to have a named award in his honor from the two international infection prevention professional societies, APIC and SHEA.

“Overall thoroughness of cleaning/disinfecting of environmental surfaces in healthcare facilities is suboptimal. The Highlight® technology should improve the thoroughness of surface disinfection in healthcare facilities, which would likely reduce microbial contamination when integrated into disinfection practices and reduce the risk of healthcare-associated infections via environmental surfaces,” said Dr. Rutala. “I am pleased to join Kinnos in their efforts to improve thoroughness of surface disinfection and reduce infection risks.”

About Kinnos Inc.

Kinnos is a New York-based company that aims to raise the standard of infection prevention to protect healthcare workers, patients, and the general public from infection. Their first product, Highlight®, is a patent-pending point-of-use additive that greatly improves visibility, coverage, and end-user compliance of disinfectants. Highlight® is used by HazMat and biosafety units, was a winner of the USAID Fighting Ebola Grand Challenge, and has been field-tested by NGOs and healthcare workers in Liberia, Guinea, and Haiti. For more information, visit:

Media Contact:

Kinnos Inc.